XtalPi

New Business

XtalPi’s 615% jump in drug revenue highlights China’s biotech boom after DoveTree deal

Shenzhen-based XtalPi posted a 615 per cent surge in first-half revenue from its drug-discovery business following a blockbuster deal that…

Read More »
Back to top button